Tau Protein after Delta-9-tetrahydrocannabinol in a Human Neuroblastoma Cell Line

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.27, Iss.7, 1996-10, pp. : 1141-1143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Changes in Microtubular Tau Protein after Morphine in a Cultured Human Neuroblastoma Cell Line

By Lew G.M.

General Pharmacology, Vol. 29, Iss. 5, 1997-11 ,pp. : 869-872

Elsevier

Access to resources Recommend Favorite

d-Lysergic Acid Reduces Microtubule-Associated Tau Protein in SH-SY5Y Human Neuroblastoma Cells

By Lew G.M.

General Pharmacology, Vol. 26, Iss. 5, 1995-09 ,pp. : 1045-1048

Elsevier

Access to resources Recommend Favorite

A drug discovery case history of ‘‘delta-9-tetrahydrocannabinol, cannabidiol’’

By Tanasescu Radu Rog David Constantinescu Cris S

Expert Opinion on Drug Discovery, Vol. 6, Iss. 4, 2011-04 ,pp. : 437-452

Informa Healthcare

Access to resources Recommend Favorite

Delta-9-tetrahydrocannabinol enhances food reinforcement in a mouse operant conflict test

By Barbano Maria Castañé Anna Martín-García Elena Maldonado Rafael

Psychopharmacology, Vol. 205, Iss. 3, 2009-08 ,pp. : 475-487

Springer Publishing Company

Access to resources Recommend Favorite

The human neuroblastoma cell line, IMR-32, expresses functional corticotropin-releasing factor receptors

By Hogg J.E. Myers J. Hutson P.H.

European Journal of Pharmacology, Vol. 312, Iss. 2, 1996-09 ,pp. : 257-261

Elsevier

Access to resources Recommend Favorite